Skip to main content
. 2021 Oct 8;413(29):7251–7263. doi: 10.1007/s00216-021-03654-4

Table 1.

Peptide identification from the in-gel digestion of the purified antigen

Protein name/
accession number
Molecular weight (Da) Position Peptide sequence Domain Sequence coverage (%) Expected value Protein score Retention time (min) Mass

Nucleoprotein/

NCAP_SARS2

45,598

33–38

62–68

94–100

101–107

144–149

196–203

250–256

294–299

362–369

SGARSK

EDLKFPR

IRGGDGK

MKDLSPR

SAAEASK

NSTPGSSR

QGTDYK

DHIGTR

TFPPTEPK

NTD

NTD

NTD

NTD

NTD

SR-rich linker

SR-rich linker

CTD

CTD

14 2.8e−05 71

1.748

10.009

8.99

14.535

11.876

3.106

8.141

4.463

17.195

605.3003

905.3679

702.3656

846.4745

663.2919

805.4151

711.3777

699.3434

916.4878

Spike Glycoprotein/

SPIKE_SARS2

141,088

35–41

196–202

238–246

305–310

409–417

458–466

530–535

568–577

815–825

987–995

1020–1028

1039–1045

GVYYPDK

NIDGYFK

FQTLLALHR

SFTVEK

QIAPGQTGK

KSNLKPFER

STNLVK

DIADTTDAVR

RSFIEDLLFNK

VEAEVQIDR

ASANLAATK

RVDFCGK

NTD

NTD

NTD

NTD

RBD

RBD

SD1

SD1

FP

HR

HR

7 3.5e−05 70

15.271

14.761

11.536

8.141

7.293

7.293

5.765

8.537

8.537

8.537

14.535

16.515

840.3916

855.4207

1099.5145

711.3777

898.4402

559.2666

660.3676

538.2224

1381.5842

1059.4718

846.4745

824.4274

Membrane/

VME1_SARS2

25,130

43–50

151–158

175–180

181–186

NRFLYIIK

IAGHHLGR

TLSYYK

LGASQR

12 0.0031 51

19.514

15.836

7.01

10.065

1065.5635

859.4678

774.3603

632.3762

ORF3a/

AP3A_SARS2

31,103

22–30

62–67

69–75

193–198

DATPSDFVR

IITLKK

WQLALSK

WESGVK

10 0.0067 47

8.537

7.575

14.535

6.387

1007.4616

716.3357

846.4745

704.3564

ORF8/

NS8_SARS2

13,822

45–52

95–101

116–121

WYIRVGAR

LGSLVVR

VVLDFI

17 0.011 45

11.536

10.009

6.387

1021.46

371.655

704.3564

Envelope/

VEMP_SARS2

8360

62–69

64–69

70–75

VKNLNSSR

NLNSSR

VPDLLV

CTD 18 0.012 38

7.575

14.705

2.653

916.4513

689.3618

655.3016

Placeholder TextPeptides with 7 amino acids or higher are considered as plausible sequences for further analyses